Editor’s note for Monday, December 28, 2020

A note from the editor of today's The China Project Access newsletter.

editor's note for Access newsletter

My thoughts today:

Iโ€™m keeping my eye on three โ€œfirstsโ€ this week:

  • One, covered in today’s top story, is that China has sentenced a citizen journalist to jailย for reporting on the early days of the COVID-19 outbreak in Wuhan.
  • Another is that regulators have begun an antitrust investigation into Alibaba, which the Financial Times callsย a โ€œone of the first of its kind for the country’s internet sector.โ€ Alibabaโ€™s Ant Group affiliate was also ordered to rectifyย its business and focus on payments, not banking.
  • A third could happen within the next few weeks, if not sooner: China may give formal approval to a COVID-19 vaccineย from Sinopharm. The SCMP saysย that Chinaโ€™s Center for Drug Evaluation โ€œhas begun reviewing an applicationโ€ for one of Sinopharmโ€™s two vaccine candidates. Sinopharm reportedly submitted that application over a month ago, and the timeline for approval is unclear. Meanwhile, many Chinese cities are expanding emergency access programsย to vaccinate more people with experimental shots.

Our word of the dayย is citizen journalistย (ๅ…ฌๆฐ‘่ฎฐ่€… gลngmรญn jรฌzhฤ›).

โ€”Lucas Niewenhuis, Newsletter Editor (lucas@thechinaproject.com)ย